Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06215079
Status:
RECRUITING
Last Update Posted:
2024-01-22
First Post:
2024-01-09
Brief Title:
Investigation of the Efficacy of Transcranial Magnetic Stimulation in Patients Developing Complex Regional Pain Syndrome Type 1 in the Upper Extremity During the Subacute-Chronic Period After Ischemic Stroke
Sponsor:
Ankara City Hospital Bilkent
Organization:
Ankara City Hospital Bilkent
Study Overview
Official Title:
Investigation of the Efficacy of Transcranial Magnetic Stimulation in Patients Developing Complex Regional Pain Syndrome Type 1 in the Upper Extremity During the Subacute-Chronic Period After Ischemic Stroke
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of our study is to investigate transcranial magnetic stimulation TMS as a treatment option in Complex Regional Pain Syndrome disseminate it to a broader patient population and simultaneously demonstrate its applicability in the treatment of complex regional pain syndrome using a novel frequency matching
Detailed Description:
After ischemic stroke in the subacute to chronic period 45 patients developing complex regional pain syndrome in the upper extremity will be divided into three groups those receiving combined rTMS with conventional rehabilitation occupational therapy and transcutaneous electrical stimulation for pain those receiving sham rTMS with conventional rehabilitation and those undergoing only conventional rehabilitation The TMS group is planned to include 15 patients the sham group 15 patients and the group included in the conventional rehabilitation program only will also consist of 15 patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None